Center Publications

Andrisse, Stanley, et al. “Low-Dose Dihydrotestosterone Drives Metabolic Dysfunction via Cytosolic and Nuclear Hepatic Androgen Receptor Mechanisms”. 2017. Endocrinology, vol. 158, no. 3, 2017, pp. 531–544.

Hakim, Christopher, et al. “Gestational Hyperandrogenism in Developmental Programming”. 2017. Endocrinology, vol. 158, no. 2, 2017, pp. 199–212.

Schmudlach, Andrew, et al. “Bottom-up Proteomics Analysis of the Secretome of Murine Islets of Langerhans in Elevated Glucose Levels”. 2017. The Analyst, vol. 142, no. 2, 2017, pp. 284–291.

Zhang, Donghong, et al. “Non-CpG Methylation by DNMT3B Facilitates REST Binding and Gene Silencing in Developing Mouse Hearts”. 2017. Nucleic Acids Research, vol. 45, no. 6, 2017, pp. 3102–3115.

Remedi, Maria S, et al. “Diabetes Induced by Gain-of-Function Mutations in the Kir6.1 Subunit of the KATP Channel”. 2017. The Journal of General Physiology, vol. 149, no. 1, 2017, pp. 75–84.

Gutiérrez, Giselle Domínguez, et al. “Pancreatic β Cell Identity Requires Continual Repression of Non-β Cell Programs”. 2017. The Journal of Clinical Investigation, vol. 127, no. 1, 2017, pp. 244–259.

Ediger, Benjamin N, et al. “LIM Domain-Binding 1 Maintains the Terminally Differentiated State of Pancreatic β Cells”. 2017. The Journal of Clinical Investigation, vol. 127, no. 1, 2017, pp. 215–229.

Qi, Weier, et al. “SHP-1 Activation Inhibits Vascular Smooth Muscle Cell Proliferation and Intimal Hyperplasia in a Rodent Model of Insulin Resistance and Diabetes”. 2017. Diabetologia, vol. 60, no. 3, 2017, pp. 585–596.

Willard, Joshua R, et al. “Improved Glycaemia in High-Fat-Fed Neprilysin-Deficient Mice Is Associated With Reduced DPP-4 Activity and Increased Active GLP-1 Levels”. 2017. Diabetologia, vol. 60, no. 4, 2017, pp. 701–708.

Mumtaz, Rizwan, et al. “Intercalated Cell Depletion and Vacuolar H-ATPase Mistargeting in an Ae1 R607H Knockin Model”. 2017. Journal of the American Society of Nephrology : JASN, vol. 28, no. 5, 2017, pp. 1507–1520.

Wacker, Bradley K, et al. “Local Vascular Gene Therapy With Apolipoprotein A-I to Promote Regression of Atherosclerosis”. 2017. Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 37, no. 2, 2017, pp. 316–327.